Moving Forward: Molten completes its acquisition of Forward Partners
Today Molten is delighted to announce that we have completed our acquisition of Forward Partners, a proposition we announced in November last year.
Find out the latest updates in the Molten portfolio.
Today Molten is delighted to announce that we have completed our acquisition of Forward Partners, a proposition we announced in November last year.
IMU Biosciences secures £11.5 million in Series A funding to revolutionise immune powered precision medicine.